Br Med J  1974;1:481-484 (16 March), doi:10.1136/bmj.1.5906.481

Salt-poor Human Albumin in Management of Nephrotic Syndrome

A. M. Davison, A. T. Lambie, A. H. Verth, J. D. Cash

Thirteen patients with the nephrotic syndrome were treated with a high-protein diet, a 0·5 g sodium intake (equivalent to 1·3 g sodium chloride), and frusemide in increasing dosage. One became oedema-free with frusemide 240 mg daily, three became oedema-free with frusemide 500 mg daily, and two required a combination of high-dose frusemide and spironolactone. In three there was an appreciable increase in the blood urea, one patient developed hyponatraemia, and in two there was no weight loss. In these six patients infusions of human salt-poor albumin produced a prompt diuresis, loss of weight, and correction of the abnormal biochemical findings. In the seventh severely oedematous patient combined albumin and diuretic therapy led to a loss of 27 kg in 14 days.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hastings, G. E., Wolf, P. G. (1992). The Therapeutic Use of Albumin. Arch Fam Med 1: 281-287 [Abstract]  
  • Ellison, D. H. (1991). The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance. ANN INTERN MED 114: 886-894 [Abstract]  
  • Erstad, B. L., Gales, B. J., Rappaport, W. D. (1991). The Use of Albumin in Clinical Practice. Arch Intern Med 151: 901-911 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ